Aristides Capital’s Smith & Wesson SWBI Stock Holding History

Aristides Capital’s Portfolio SWBI Stock Details SWBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-11,616	Closed	-$206K	–	170
2020 Q4	$206K	Buy	+11,616	New	+$192K	0.07%	106

Other funds holding SWBI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Aristides Capital's SWBI Position: Q1 2021 in Review

Aristides Capital sold out of Smith & Wesson (SWBI) in Q1 2021, closing a stake of 11,616 shares — an estimated $206K sold.

Aristides Capital first reported a position in SWBI in Q4 2020 and held it in 1 quarter. The position peaked at $206K in Q4 2020. 217 funds tracked by Wall St. Rank hold SWBI as of Q1 2021.

Aristides Capital reported no remaining Smith & Wesson position as of Q1 2021 after selling out during the quarter.
Aristides Capital sold 11,616 Smith & Wesson shares in Q1 2021, an estimated $206K.
Aristides Capital first reported a position in Smith & Wesson in Q4 2020 and held it in 1 quarter.
Aristides Capital's Smith & Wesson position peaked at $206K in Q4 2020.
217 funds tracked by Wall St. Rank held Smith & Wesson as of Q1 2021.

Based on Aristides Capital's 13F filing for Q1 2021, filed 17 May 2021.